NDAORALTABLETPriority Review
Lifecycle
Pre-Launch
Clinical Trials
1
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Darunavir and ritonavir is an oral tablet combining a protease inhibitor (darunavir) with a pharmacokinetic booster (ritonavir) for the treatment of HIV infection. This fixed-dose combination is designed to simplify antiretroviral therapy by reducing pill burden. The combination works by inhibiting HIV protease, preventing viral replication in infected individuals.
Pre-Launch
Pre-launch stage indicates early commercial planning and infrastructure building; team expansion likely focused on launch readiness and market access roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Started Apr 2009
77 enrolled
HIVHIV InfectionsPregnancy
Career Relevance
Working on this pre-launch product offers career opportunity to be part of a pivotal market entry for a simplified HIV treatment option at Viatris. Team growth is anticipated across commercial, medical, and regulatory functions as launch infrastructure scales.
Brand Manager
Worked on DARUNAVIR AND RITONAVIR at Viatris? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.